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Protease nexin-1, a serine protease inhibitor, is ex-
pressed speci¢cally in the dermal papilla (DP) of ana-
gen hair follicles and is suggested to be one of the
modulators of the cyclic growth of hair follicles. Accu-
mulating evidence has shown that protease nexin-1
plays its biologic role by inhibiting thrombin action in
various systems other than the hair follicle. Thrombin
has various physiologic functions including blood coa-
gulation cascade, mostly via activation of protease-acti-
vated receptors (PAR). In this study, we investigated the
expression of PAR mRNA using RT-PCR in dissected
human hair follicles.We showed that PAR-1 mRNAwas
expressed speci¢cally in the mesenchymal portions, in-
cluding DP and connective tissue sheath, of anagen hair
follicles. Furthermore, immunoreactivity for PAR-1
was detected in the DP and lower portion of connective
tissue sheath in the anagen and catagen phases and in
the DP of telogen hair follicles. Because only a pharma-
cologic level (100 nM) of thrombin signi¢cantly sti-
mulated cell proliferation and DNA synthesis of the
cultured dermal papilla cells, thrombin does not seem
to have a mitogenic e¡ect on dermal papilla cells phy-
siologically. These results raise the possibility that
thrombin is involved in the cyclic hair growth through
its receptor of PAR-1. Keywords: protease nexin-1/hair
cycle/dermal papilla/RT-PCR/immunohistochemistry. J Invest
Dermatol 121:669 ^673, 2003
T
he hair follicle grows with cyclic morphologic
changes during its lifetime. It consists of epithelial
portions composed of outer and inner root sheath,
matrix, and mesenchymal portions including con-
nective tissue sheath (CTS) and dermal papilla (DP).
DP contains highly specialized ¢broblasts, which have the ability
to induce follicle neogenesis (Jahoda et al, 1984) and to synthesize
basement-membrane-type extracellular matrices (Messenger et al,
1991). The epithelial^mesenchymal interaction plays an important
role in the development and the cyclic changes of hair follicles.
The interaction is thought to be mediated by various cytokines,
growth factors, hormones, enzymes, and receptors (Stenn and Paus,
2001). Recently, protease nexin-1 (PN1), a serine protease inhibitor,
has been reported to be a new candidate for a modulator of the hair
cycle (Yu et al, 1995). PN1mRNAwas expressed speci¢cally in DP
of human and mouse hair follicles during anagen, but not during
catagen and telogen (Jensen et al, 2000). Its expression level in rat DP
cell lines correlated with their ability to reconstruct hair follicles (Yu
et al, 1995). Furthermore, we showed that PN1 mRNA was ex-
pressed in human DP as well, and its expression level in cultured
dermal papilla cells (DPC) was signi¢cantly suppressed by andro-
gen, speci¢cally in those obtained from a balding scalp (Sonoda
et al, 1999). These observations suggest that PN1 is involved in the
cyclic growth of hair follicles. PN1, a secreted protein, inhibits ser-
ine proteases including thrombin, urokinase-type plasminogen acti-
vator, tissue plasminogen activator, plasmin, and trypsin by forming
irreversible complexes with them at their catalytic sites in the ex-
tracellular environment (Scott et al, 1985). Among these serine
proteases, thrombin regulates various physiologic or pathologic
processes, such as development (Connolly et al, 1996), cell prolifera-
tion (Pohjanpelto, 1978; Pakala et al, 2001;Wang et al, 2002), apoptosis
(Donovan et al, 1997; Smirnova et al, 1998;Turgeon et al, 1998; Ahmad
et al, 2000), neurite retraction (Gurwitz and Cunningham, 1990),
synapse elimination at the neuromuscular junction (Kim
et al, 1998), cytokine production (Bydlowski et al, 1998; Stou¡er
and Runge, 1998; Chambers et al, 2000; Szaba and Smiley 2002),
and tumor cell metastasis (Nierodzik et al, 1998). In the nervous tis-
sues, because most of these actions of thrombin are controlled by
PN1, thrombin is thought to be a principal target enzyme for PN1
(Gurwitz and Cunningham, 1990; Kim et al, 1998). The action of
thrombin is mediated by its receptors. Three isotypes of thrombin
receptors, protease-activated receptor (PAR)-1, -3, and -4, have been
cloned in humans.Their N-terminal extracellular domain is cleaved
by thrombin, resulting in the exposure of the new amino acid se-
quence, which is called tethered ligand, and it acts as an intramole-
cular agonist. This intramolecular event contributes to signal
transduction through the cell membrane. In this study, we investi-
gated the localization of thrombin receptors in human hair follicles
using RT-PCR and immunohistochemistry. Furthermore, we stu-
died the e¡ects of thrombin on the viability of cultured DPC.
MATERIALS ANDMETHODS
Dissection of hair follicles Human hair follicles were dissected as
described previously (Sonoda et al, 1999; Asada et al, 2001). Anagen hair
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follicles were isolated from surplus nonbalding scalp skin obtained during
plastic surgery after obtaining informed consent as approved by the ethical
committee of Oita Medical University. Under a binocular microscope,
each hair follicle was dissected into ¢ve portions including DP, upper and
lower CTS, upper epithelial portion including inner and outer root sheath,
and lower epithelial portion including the matrix cells around the DP.
Brie£y, the hair follicle was cut just below the sebaceous gland. It was
then cut horizontally above the tip of the DP. The bulbar portion (lower
epithelial portion) and the surrounding lower CTS were loosely attached
to each other. The latter was inverted from the lower epithelial portion
and was dissected from the DP. Thus, a part of the upper CTS and the
whole lower CTS undergoes cycles of growth. These portions dissected
from approximately 20 hair follicles were subjected to RNA extraction.
RT-PCR Total RNA was extracted from each sample of the ¢ve
portions using Isogen (Nippon Gene, Tokyo, Japan) according to the
manufacturer’s instructions. It was dissolved in double-distilled water that
had been treated with diethyl pyrocarbonate, and stored at ^701C before
analysis. One microgram of the total RNA was incubated in 17.0 mL of
the diethyl pyrocarbonate-treated water containing 0.5 mg of oligo(dT)15
primer for 10 min at 701C and then quickly chilled on ice for 2 min.
Added to the reaction mixture was 2 mL of 200 units/mL Moloney
murine leukemia virus reverse transcriptase (Gibco BRL, Tokyo, Japan); 1
unit of RNase inhibitor (Wako, Osaka, Japan); 8 mL of 2.5 mM of each
dNTP; and 8.0 mL of 5 ¢rst-strand bu¡er, which consisted of 250 mM
Tris-HCl (pH 8.3), 375 mM KCl, 15 mM MgCl2, and 4.0 mL of 0.1 M
dithiothreitol in a ¢nal volume of 40 mL. The reaction was then incubated
for 1 h at 421C and for an additional 10 min at 901C. PCRwas performed
in 25 mL of reaction mixture, which contained 0.65 units of Taq DNA
polymerase (Takara, Kyoto, Japan), 200 mM dNTPs, 0.5 mM primers, 50
mM KCl, 10 mM Tris-HCl (pH 9), 1.5 mM MgCl2, and 0.5 mL of cDNA
using a thermal cycler (Astec, Fukuoka, Japan). The following sets of
primers, which were complementary to the human cDNA, were used for
PCR. PAR-1, sense 50 -TGT GAA CTG ATC ATG TTTATG-30, antisense
50 -TTC GTA AGA TAA GAG ATA TGT-30 (Vu et al, 1991); PAR-3, sense
50 -GCT TCCATT TGC TGC TGACACATG-30, antisense 50 -GCTCCT
TGC ACT ATG CTT ATG TTG-30 (Hauck et al, 1999); PAR-4, sense 50 -
TGG CAC TGC CCC TGA CAC TGC A-30; antisense 50 -CCC GTA
GCA CAG CAG CAT GG-30 (Xu et al, 1998); and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), sense 50 -CCC ATC ACC ATC TTC
CAG-30, antisense 50 -CCT GCT TCA CCA CCT TCT-30 (Sonoda et al,
1999). Expected sizes of ampli¢ed products of PAR-1, -3, and -4 and
GAPDH are 708, 1302, 176, and 577 bp, respectively. PCR programs for
PAR-1, -3, and -4 were as follows. Denaturation (941C; 1 min), annealing
(551C; 1 min), and extension (721C; 1 min) for 34 (PAR-1) or 38 (PAR-3
and -4) cycles with the exception that the ¢rst denaturation step was
allowed to proceed for 5 min, and the ¢nal extension step for 3 min. Ten
microliters of PCR products was subjected to electrophoresis on 1.2%^
2.0% agarose gels containing ethidium bromide. The bands visualized
under ultraviolet light were photographed. The densities of the bands
of GAPDH were digitized to con¢rm that there was no signi¢cant
di¡erence in the amount of mRNA used for RT-PCR among the
samples. The expression levels of the PAR mRNAwere normalized with
the levels of GAPDH. The PCR products were puri¢ed using DNA and
gel band puri¢cation kit (Amersham Pharmacia Biotech Inc., Piscataway,
NJ), and their identities were con¢rmed by the sequence analyses by
means of direct Big Dye labeling using an ABI 310 genetic analyzer
(Applied Biosystem,Tokyo, Japan).
Immunohistochemistry Tissue sections obtained from the scalps of
patients undergoing plastic surgery were used for the immuno-
histochemical localization of PAR-1. The blocks of resected skins were
buried in Tissue-Tek OCT compound (Miles, Elkhart, IN), snap-frozen in
liquid nitrogen, and then stored at ^701C until processed. The tissue
sections, which were cut to a thickness of 5 mm with a cryostat (Leica
Instruments GmbH, Nussloch, Germany), were placed on silanized slides
(Dako, Kyoto, Japan), air-dried for 30 min at room temperature, and then
stored at ^701C until use. For the immuno£uorescence study, the sections
were thawed, ¢xed in cold (41C) acetone for 10 min, rinsed in cold
phosphate-bu¡ered saline (PBS) twice, preincubated with PBS containing
5% skim milk, incubated with the ¢rst antibody of ATAP2 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA), namely mouse monoclonal IgG
against amino acids 42^55 of human PAR-1 or mouse IgG1 (Dako) as a
negative control for 1 h, and then incubated with the second antibody
of goat anti-mouse IgG conjugated with £uorescein isothiocyanate. The
¢rst and second antibodies were diluted 1:50 with PBS containing 5%
skim milk and 1:100 with PBS, respectively. All the reactions with the
antibodies were performed in a humidi¢ed chamber at room temperature.
For the immunohistochemical study, all procedures from preparation of
tissue sections to reaction with the ¢rst antibody were performed as
described in the immuno£uorescent study. The sections were incubated
with biotinylated link anti-mouse Ig and streptavidin^horseradish peroxi-
dase contained in LSAB2 system (Dako) for 10 min and then with
streptavidin^horseradish peroxidase for 10 min and ¢nally reacted with
horseradish peroxidase substrate mixture (Santa Cruz Biotechnology, Inc.).
Cell culture DPC obtained from the human hair follicles were cultured
as previously described (Itami et al, 1991; Sonoda et al, 1999). Brie£y, DP
dissected from the anagen hair follicles were placed on tissue culture
dishes, and the culture was maintained for approximately 2 weeks before
the ¢rst passage. The cells were maintained in Dulbecco’s modi¢ed Eagle’s
medium supplemented with 10% fetal bovine serum, 0.1 mM nonessential
amino acid solution (Gibco BRL, Tokyo, Japan), 20 mM L-glutamine,
penicillin (50 units/mL), and streptomycin (50 mg/mL) in a humidi¢ed
atmosphere of 5% CO2 in air at 371C. Culture medium was changed
every 3 d. DPC after four to six passages were used in this study.
Cell viability
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay The
cultured DPC were plated on a 96-well plate at 5103 per well, incubated
in the presence of 10% fetal bovine serum for 24 h and then incubated in
serum-free Dulbecco’s modi¢ed Eagle’s medium for 48 h (quiescent cul-
ture). The cells were subsequently incubated in the serum-free medium,
which contained di¡erent concentrations of a-thrombin (Calbiochem,
Los Angeles, CA), for 48 and 96 h. In the latter incubation period, throm-
bin was newly added at 48 h. The cells were then incubated with MTT
solution (0.5 mg/mL) for an additional 4 h. The reaction was stopped by
adding 100 mL of 0.04 N HCl/isopropanol. Absorbance was measured with
an ELISA reader at 540 nm (reference wavelength, 690 nm).
Bromodeoxyuridine (BrdU) incorporation DPC were plated and incubated
as described in the MTT assay. After 48 h of quiescent culture, DPC
were incubated in the serum-free medium in the presence of di¡erent
Table I. Expression of PARs mRNA in human hair folliclesa
PAR-1 PAR-3 PAR-4
Age (y) Site UCTS UEP LEP LCTS DP UCTS UEP LEP LCTS DP UCTS UEP LEP LCTS DP
37 F (B) þ ^ ^ þ þ ^ ^ ^ ^ ^ ^ þ þ þ þ
37 O þ ^ ^ þ þ ^ ^ ^ ^ ^ þ þ þ þ þ
31 O þ ^ ^ þ þ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^
30 T ^ ^ ^ þ þ ^ ^ ^ þ ^ ^ ^ ^ ^ ^
32 O þ ^ ^ þ þ ^ ^ ^ þ ^ ^ ^ ^ ^ ^
58 P (B) þ ^ ^ þ þ þ ^ ^ ^ ^ þ ^ þ ^ ^
24 F (B) þ ^ ^ þ þ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^
40 F (B) þ ^ ^ þ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^
40 O þ ^ ^ þ þ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^
aUsing speci¢c primers for PAR-1, -3, and -4, RT-PCRwas performed on each portion of dissected hair follicles obtained from nine subjects. All subjects were male. F,
frontal; O, occipital; T, temporal; P, parietal; B, balding; UCTS, upper CTS; UEP, upper epithelial portion; LEP, lower epithelial portion; LCTS, lower CTS; PAR,
protease-activated receptor; þ, detected; ^, not detected.
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concentrations of a-thrombin or synthesized tethered ligand peptide of
PAR-1, SFLLRN (Sawady Technology Co., Ltd, Tokyo, Japan), for 16 h,
followed by an additional culture for 16 h in the presence of BrdU. The
incorporation of BrdU was measured using a cell proliferation ELISA kit
(Roche Diagnostics KK,Tokyo, Japan) according to the manufacturer’s in-
structions. Absorbance was measured with an ELISA reader at 450 nm (re-
ference wavelength, 690 nm).
Statistical analysis The results were statistically analyzed using the
Wilcoxon signed-ranks test. p values of o0.05 was taken to be statistically
signi¢cant.
RESULTS
Expression of PARs mRNA in human hair follicles RT-
PCR was performed using dissected human hair follicles for
PAR-1, -3, and -4 to localize them and to clarify which PAR is
the major receptor. The expression of PAR-1 mRNA was
detected in almost all of the mesenchymal portions, namely
upper CTS, lower CTS, and DP, but not in the epithelial
portions (Table I, Fig 1). A minority of samples of upper CTS
and lower CTS expressed PAR-3 and -4 as well (Table I).
Localization of PAR-1 protein in human hair
follicle Because PAR-1 mRNA was expressed constantly in
the mesenchymal portions, we further investigated the
localization of PAR-1 protein in human hair follicles. The
epidermis of scalp skin was used as a positive control
(Algermissen et al, 2000). Obvious staining of PAR-1 in the
spinous layer of the epidermis was obtained (Fig 2A). In the late
anagen hair follicle, PAR-1 immunoreactivity was clearly
observed along the CTS and at the bottom of DP (Fig 2C,E).
Immunostaining with the LSAB system revealed more detailed
localization of PAR-1 in the DP (Fig 2G) and CTS, especially
the inner layer and contiguous to DP (Fig 2F,G). The PAR-1
expression in CTS was restricted to its lower portion, which
undergoes cycles of growth (Fig 2E,F), whereas it was not
observed in the upper permanent portion (data not shown). The
epithelial portions, such as matrix, inner, and outer root sheath
were always negative for the immunoreactivity of PAR-1
(Fig 2C,E,F,G). Thus the results con¢rm the ¢ndings with RT-
PCR (Table I). In the catagen hair follicle, PAR-1 staining was
observed in the thick glassy membrane of CTS and the DP
(Fig 3A). In the late catagen hair follicle, it was clearly shown
that PAR-1 was localized in the involuted DP and the adjacent
CTS, which undergoes destruction and restoration associated
with hair cycle (Panteleyev et al, 2001) (Fig 4B). No
immunoreactivity of PAR-1was observed in either the follicular
epithelium or the upper part of CTS (Fig 4B). In the telogen hair
follicle, the expression of PAR-1 was limited to the ball-shaped
DP attached to the germ hair cap (Fig 4E). In the early anagen
hair follicle, PAR-1 immunoreactivity was observed in DP as
well as in the CTS (Fig 4H).
Figure1. RT-PCR detects mRNA of PAR-1. PAR-1was expressed in
upper and lower CTS and DP. Identity of each band was con¢rmed by
nucleotide sequencing. UCTS, upper CTS; UEP, upper epithelial portion;
LEP, lower epithelial portion; LCTS, lower CTS, DP, dermal papilla.
Figure 2. Immuno£uorescent and immunohistochemical localiza-
tion of PAR-1 in the late anagen hair follicles. (A) Positive staining
is seen in spinous cells and (C) CTS and at the bottom of DP. (E^G) Im-
munoreactivity is stronger in the inner layer of CTS and at the bottom of
DP. (B,D,H) Mouse IgG1 is used to show nonspeci¢c staining. Matrix
portion (MTX) of a hair follicle; ORS, outer root sheath. Bar, 100 mm.
Figure 3. Immuno£uorescent localization of PAR-1 in the catagen
hair follicle. (A) On 5-mm cryosections of human scalp skin, ATAP2
stained thick glassy membrane and the DP. No staining was observed
when mouse IgG1was used instead (B). CH, club hair; ES, epithelial strand;
GM, glassy membrane. Bar, 100 mm.
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E¡ects of thrombin and synthetic tethered ligand peptide of
PAR-1 on the viability of DPC To explore the biologic role
of thrombin in the cyclic growth of hair follicles, the e¡ects of
thrombin on the viability of cultured DPC were examined.
MTT assay, which re£ects the numbers of viable cells, showed
that higher concentrations (10 and 100 nM) of a-thrombin
increased cell viability at 96 h, whereas the number of viable
cells continuously decreased with time at lower concentrations
(0.01^1 nM) and in the control (Fig 5A). The rate of
incorporation of BrdU, which re£ects DNA synthesis, was
promoted by adding 100 nM a-thrombin by about 50%
(Fig 5B), but no signi¢cant e¡ect was observed at physiologic
concentrations of a-thrombin (0.01^10 nM). BrdU incorporation
was not changed by adding the synthetic tethered ligand peptides
of PAR-1 up to 1000 mM (Fig 5C). An obvious morphologic
change such as apoptosis, which had been observed in the
studies with astrocytic, microglial, and neuronal cell populations
(Donovan et al, 1997; Smirnova et al, 1998;Turgeon et al, 1998), was
observed upon adding neither a-thrombin nor the synthetic
tethered ligand peptides (data not shown).
DISCUSSION
In this study, we showed that PAR-1was expressed in human hair
follicles and its major site of the expression was the mesenchymal
portions, namely in the DP and CTS.The PAR-1mRNAwas con-
stantly expressed in the CTS and DP of anagen hair follicles. The
immunohistochemical staining was also positive in the DP and
the lower part of the CTS of anagen follicles. In the catagen hair
Figure 4. Immuno£uorescent localization of PAR-1 in the late cata-
gen, telogen, and early anagen hair follicles. (B) In fully involuted
catagen hair follicle, DP and the lower part of CTS contiguous to DP were
positive for PAR-1. (E) In the telogen, the expression of PAR-1was limited
to DP. In the early anagen hair follicle, PAR-1 immunoreactivity was ob-
served in DP, as well as in the lower part of CTS (H). Late catagen hair
follicle (A^C), telogen hair follicle (D^F), and early anagen hair follicle
(G^I). Hematoxylin and eosin staining (A,D,G). Mouse IgG1 (C,F,I). CH,
club hair; GC, germ capsule; ES, epithelial strand;TCTS, trailing connec-
tive tissue sheath. Bar, 100 mm.
Figure 5. E¡ects of thrombin and synthetic tethered ligand peptide
of PAR-1 on DPC viability. (A) DPC were deprived of serum for 48 h
and subsequently exposed to the indicated concentrations of a-thrombin
dissolved in serum-free medium for 48 and 96 h. Cell viability was assessed
by the MTT method. The value represents the percentage of those at 0
time. Each point represents the mean of the three independent experi-
ments. Thrombin concentration was 0 nM (E), 0.01 nM (’), 0.1 nM
(), 1 nM (B), 10 nM (&), and 100 nM (J), respectively. (B) The
e¡ects of a-thrombin and (C) synthetic tethered ligand peptide of PAR-1
on DNA synthesis by DPC.The DNA synthesis was evaluated by the incor-
poration of BrdU after DPCwere incubated with various concentrations of
a-thrombin or the tethered ligand peptide dissolved in serum-free medium
for 16 h. Each value represents the percentage of the value of the control
(thrombin-free). Results represent the mean7SD of 10 independent ex-
periments. n¼10. po0.05.
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follicle, the immunoreactivity for PAR-1was also restricted to the
DP and the lower part of CTS which undergoes cycles of growth,
whereas it was observed in the DP only of the telogen follicles.
The DP and the lower part of CTS contain ample amounts of
extracellular matrix (ECM) components (Messenger et al, 1991).
Both the DP volume and the expression of ECM components
vary in concert with the hair growth cycle (Messenger et al,
1991). Di¡erences of the DP volume are considered to be due to
ECM volume and cell number (Elliot et al, 1999). Thrombin af-
fects synthesis of ECM components such as procollagen (Cham-
bers et al, 1998), ¢bronectin (Armstrong et al, 1996), and laminin
and collagen I and IV (Papadimitriou et al, 1997) in various kinds
of cells mostly through PAR-1 activation. Besides, thrombin acti-
vates matrix metalloproteinases (Duhamel-Clerin et al, 1997;
La£eur et al, 2001; Maragoudakis et al, 2001), some of which
are present in the human hair follicle (Goodman and Ledbetter,
1992; McGowan et al, 1994; Jarrousse et al, 2001).
To know the biologic role of thrombin in hair follicles, we ex-
amined the e¡ects of thrombin on the viability of cultured DPC
in the serum-free medium. Although thrombin appeared to in-
duce marginal stimulation of DPC at the highest concentration
employed, more than 100 times higher concentration was re-
quired, compared with the other mesenchymal cells (Pohjanpelto,
1978; Herbert et al, 1994; Armstrong et al, 1996; Pakala et al, 2001).
Whether thrombin has direct e¡ect on DPC remains unknown.
It is tempting to hypothesize that thrombin and PAR-1 play some
role in the hair growth or hair cycle by modulating ECM in the
DP or through activation of matrix metalloproteinases. The sig-
ni¢cance of the presence of PAR-1 in the hair follicle is un-
known, however, as far as no direct evidence has been presented
that thrombin is involved in hair follicle physiology.
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